Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cervical Cancer and HPV Research, and Uterine Myomas and Treatments.
Comparison of ultrasound with computed tomography and whole-body diffusion-weighted MRI in prediction of surgical outcome using ESMO-ESGO criteria in patients with tubo-ovarian carcinoma: prospective ISAAC study.
The future of gynecologic oncologic surgery: a narrative review of current surgical trials.
Sentinel lymph node biopsy in vulvar cancer: current evidence, limitations, and future perspectives
Incorporating immune checkpoint inhibitors in epithelial ovarian cancer
TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7).
Malignant germ cells tumor of the ovary
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis
Malignant germ cells tumor of the ovary.
Assessing the Reliability of Hysteroscopic Sampling Methods for Diagnosing Atypical Endometrial Hyperplasia
Reliability of hysteroscopic sampling methods in diagnosing atypical endometrial hyperplasia: a matched cohort study
Long-term survival analysis of a randomized phase II study of front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer (QPT-ORE-002).
A STUDY OF NIRAPARIB IN COMBINATION WITH ABEMACICLIB FOR LATE LINE TREATMENT OF OVARIAN CANCER: A SINGLE CENTER, OPEN LABEL, SINGLE ARM, PHASE IB/II TRIAL (NICHOL TRIAL NCT06594679)
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes
Targeting BRAF pathway in low-grade serous ovarian cancer.
Sentinel node mapping in endometrial cancer.
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix
Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer
Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression.
1060 The role of VY flap reconstruction in vulvar cancer patients: a multicenter retrospective study
733 Real world data of niraparib in platinum sensitive relapsed ovarian cancer: a multicenter experience of the MITO group
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
Tisotumab vedotin in recurrent or metastatic cervical cancer
Gestational choriocarcinoma